Subfoveal Fibrosis Associated With AMD Linked To Classic CNV, Significant Vision Loss

Monday, August 5, 2013

Ocular Surgery News

Subfoveal fibrosis in age-related macular degeneration was associated with the development of classic choroidal neovascularization, poorer visual acuity, longer duration of disease and greater visual loss, according to a study.

Full Story

All of the following drugs are FDA approved for the treatment of minimally classic subfoveal CNV in patients with neovascular AMD with evidence of recent disease progression (loss of vision, growth of CNV on FA, new macular hemorrhage) except for which one?
1. Pegaptanib sodium (Macugen)
2. Verteporfin (Visudyne PDT)
3. Ranibizumab (Lucentis)
4. None of the above
5. All of the above
Check The Answer

CareCloud Charts For Ophthalmology
Get all of the tools you need to deliver... view product
Volk iNview
iPhone Fundus Camera The Volk iNview ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Subfoveal Fibrosis Associated With AMD Linked To Classic CNV, Significant Vision Loss

Comments

Quick Quiz

All of the following drugs are FDA approved for the treatment of minimally classic subfoveal CNV in patients with neovascular AMD with evidence of recent disease progression (loss of vision, growth of CNV on FA, new macular hemorrhage) except for which one?

AdGlare RMR Ad

Featured Products

CareCloud Charts For Ophthalmology

Volk iNview

Follow OphthalmologyWeb

Write for Us

AdGlare RMR2